NDC 0904-7172 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC0904-7172

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Major Pharmaceuticals
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA212114
Marketed since
July 26, 2019
Listing expires
December 31, 2027
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
0904-7172-0730 BLISTER PACK in 1 CARTON (0904-7172-07) / 1 TABLET, FILM COATED in 1 BLISTER PACKJul 26, 2019

Other Emtricitabine and tenofovir disoproxil fumarate products